Plain English Breakdown
The plain English breakdown is still being put together. The official documents below are already here.
Straight-ahead summaries built from the official bill text. We keep the source links front and center and leave the decision up to you.
HB3817 • 2025
Directs the Oregon Health Authority and the Department of Veterans' Affairs to study the consumption of ibogaine by certain individuals for the purpose of treating specified disorders.
This bill passed both chambers and reached final enrollment, even if later executive action is not shown here.
The plain English breakdown is still being put together. The official documents below are already here.
In committee upon adjournment.
Recommendation: Do pass with amendments, be printed A-Engrossed, and be referred to Ways and Means.
Referred to Ways and Means by order of Speaker.
Work Session held.
Public Hearing held.
Referred to Behavioral Health and Health Care.
First reading. Referred to Speaker's desk.
<b>Digest: The Act tells OHA and DVA to study the use of ibogaine by some people to help treat certain disorders. (Flesch Readability Score: 68.0).</b> [<i>Digest: The Act tells OHA and DVA to set up a process to let a person with a certain disorder use ibogaine to help treat the disorder. (Flesch Readability Score: 63.3).</i>] Directs the Oregon Health Authority [<i>in collaboration with</i>]<b> and</b> the Department of Veterans' Affairs to [<i>establish a process through which a certain individual may consume ibogaine for a specified purpose</i>]<b> study the consumption of ibogaine by certain individuals for the purpose of treating specified disorders</b>. Defines "ibogaine." Requires the authority and the department to submit a report to the interim committees of the Legislative Assembly related to health care [<i>and veterans</i>] not later than September 15, 2029. [<i>Exempts ibogaine, when obtained and consumed through the established process, from the definition of "controlled substance."</i>] Sunsets on January 2, 2030. Relating to: Relating to ibogaine. Current location: In House Committee